Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods

Details for Australian Patent Application No. 2009296235 (hide)

Owner Gilead Sciences, Inc.

Inventors Belardinelli, Luiz; Blackburn, Brent

Agent Freehills

Pub. Number AU-A-2009296235

PCT Pub. Number WO2010/037122

Priority 61/101,043 29.09.08 US

Filing date 29 September 2009

Wipo publication date 1 April 2010

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/522 (2006.01)

A61K 31/7076 (2006.01)

A61K 49/00 (2006.01) Preparations for testing

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

31 March 2011 PCT application entered the National Phase

  PCT publication WO2010/037122 Priority application(s): WO2010/037122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296242-Array of nozzles with stable flat spray patterns

2009296232-Enhanced iron-sulfur cluster formation for increased dihydroxy-acid dehydratase activity in lactic acid bacteria